tradingkey.logo
搜索
市场行情
自选
新闻
分析
交易工具
选股器
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
搜索

Neurocrine Biosciences Inc

NBIX
添加自选
166.800USD
-18.700-10.08%
收盘 07-31 16:00（美东）报价延迟15分钟
16.95B总市值
24.90市盈率 TTM

Neurocrine Biosciences Inc

166.800
-18.700-10.08%
概览
财务
分析
公司
财务摘要利润表资产负债表现金流量表

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

NBIX 财务数据

通过专为投资者打造的一站式数据看板，全面查看 Neurocrine Biosciences Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

Neurocrine Biosciences Inc财报日历

最新发布
7月 30, 2026
每股收益 / 预测值
1.43/1.34
营业收入 / 预测值
959.00M/885.80M
查看即将公布的财报 >>
报告期
FY2025 财报
营业收入(YoY)
2.86B
21.45%
每股收益(YoY)
4.81
41.50%
分析师评级
BUY
2026/07/31
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
31.69%1.43
2385.05%1.97
48.63%1.54
64.16%2.11
68.39%1.09
-81.78%0.08
-31.25%1.03
51.25%1.28
-34.10%0.64
155.12%0.43
62.75%1.50
--0.85
--0.98
---0.79
--0.92
--0.69
----
----
----
----
营业收入
39.49%959.00M
42.25%814.50M
28.33%805.50M
27.78%794.90M
16.49%687.50M
11.12%572.60M
21.84%627.70M
24.72%622.10M
30.37%590.20M
22.57%515.30M
25.05%515.20M
28.59%498.80M
19.70%452.70M
35.35%420.40M
32.05%412.00M
31.05%387.90M
30.91%378.20M
31.28%310.60M
25.86%312.00M
14.51%296.00M
净利润
----
2405.06%197.90M
49.08%153.70M
61.40%209.50M
65.38%107.50M
-81.80%7.90M
-30.20%103.10M
56.20%129.80M
-31.94%65.00M
156.66%43.40M
65.96%147.70M
21.31%83.10M
665.09%95.50M
-651.08%-76.60M
1319.18%89.00M
204.44%68.50M
-139.95%-16.90M
-56.70%13.90M
-102.10%-7.30M
139.06%22.50M
利润率
----
1661.08%24.30%
16.17%19.08%
26.32%26.36%
41.98%15.64%
-83.62%1.38%
-42.71%16.43%
25.24%20.86%
-47.79%11.01%
146.22%8.42%
32.71%28.67%
--16.66%
--21.10%
---18.22%
--21.60%
--6.08%
----
----
----
----
毛利率
-2.53%95.87%
-0.09%98.31%
-0.71%97.82%
-0.48%98.24%
-0.09%98.36%
-0.15%98.39%
0.17%98.52%
0.98%98.71%
1.01%98.44%
0.58%98.54%
0.22%98.35%
--97.75%
--97.46%
--97.98%
--98.13%
--98.56%
----
----
----
----
资产负债率
----
----
----
----
----
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-50.76%3.54%
-26.85%5.23%
--5.97%
--6.49%
--7.18%
--7.15%
--7.89%
----
----
----
----
利润表
营业收入
39.49%959.00M
42.25%814.50M
28.33%805.50M
27.78%794.90M
16.49%687.50M
11.12%572.60M
21.84%627.70M
24.72%622.10M
30.37%590.20M
22.57%515.30M
25.05%515.20M
28.59%498.80M
19.70%452.70M
35.35%420.40M
32.05%412.00M
31.05%387.90M
30.91%378.20M
31.28%310.60M
25.86%312.00M
14.51%296.00M
营业利润
5.08%153.00M
684.81%186.00M
57.17%227.90M
29.49%239.30M
-1.56%145.60M
-77.49%23.70M
-3.53%145.00M
30.88%184.80M
100.95%147.90M
254.55%105.30M
45.36%150.30M
60.82%141.20M
34.55%73.60M
858.06%29.70M
61.56%103.40M
97.30%87.80M
-19.32%54.70M
-90.16%3.10M
-10.86%64.00M
-40.03%44.50M
净利润
----
2405.06%197.90M
49.08%153.70M
61.40%209.50M
65.38%107.50M
-81.80%7.90M
-30.20%103.10M
56.20%129.80M
-31.94%65.00M
156.66%43.40M
65.96%147.70M
21.31%83.10M
665.09%95.50M
-651.08%-76.60M
1319.18%89.00M
204.44%68.50M
-139.95%-16.90M
-56.70%13.90M
-102.10%-7.30M
139.06%22.50M
资产负债表
流动资产
-6.37%1.64B
48.73%2.44B
46.27%2.52B
15.02%2.16B
4.74%1.75B
-8.95%1.64B
7.32%1.72B
13.74%1.88B
11.57%1.67B
25.56%1.80B
10.56%1.61B
36.86%1.65B
46.83%1.50B
40.72%1.43B
49.41%1.45B
19.87%1.21B
-8.18%1.02B
-6.19%1.02B
-4.27%972.80M
-13.07%1.01B
流动负债总额
60.08%874.50M
59.06%831.70M
46.43%743.40M
48.48%638.00M
37.09%546.30M
-26.65%522.90M
-22.46%507.70M
-37.87%429.70M
-31.59%398.50M
90.56%712.90M
21.78%654.80M
42.57%691.60M
103.89%582.50M
47.57%374.10M
118.76%537.70M
114.74%485.10M
34.19%285.70M
33.42%253.50M
31.80%245.80M
-63.03%225.90M
总资产
37.77%5.36B
33.04%4.91B
24.55%4.63B
20.67%4.27B
17.69%3.89B
6.20%3.69B
14.37%3.72B
24.11%3.54B
26.48%3.31B
47.15%3.47B
37.27%3.25B
32.88%2.85B
30.28%2.61B
10.04%2.36B
14.29%2.37B
6.25%2.14B
2.52%2.01B
16.14%2.14B
19.47%2.07B
34.25%2.02B
总负债
39.31%1.67B
30.10%1.50B
22.09%1.38B
54.65%1.26B
50.23%1.20B
6.05%1.15B
10.75%1.13B
-3.55%816.10M
4.70%795.80M
60.86%1.09B
54.24%1.02B
41.30%846.10M
30.53%760.10M
-10.37%675.30M
-5.38%660.90M
-10.80%598.80M
-14.01%582.30M
17.57%753.40M
14.79%698.50M
-3.87%671.30M
总权益
37.09%3.69B
34.38%3.41B
25.62%3.25B
10.47%3.00B
7.38%2.69B
6.27%2.54B
16.03%2.59B
35.80%2.72B
35.41%2.51B
41.65%2.39B
30.69%2.23B
29.62%2.00B
30.18%1.85B
21.09%1.68B
24.29%1.71B
14.75%1.54B
11.27%1.42B
15.39%1.39B
22.00%1.37B
67.35%1.35B
现金流量表
经营净额
33.73%136.40M
125.00%145.80M
60.16%388.40M
43.99%227.50M
57.89%102.00M
-50.27%64.80M
96.36%242.50M
-25.47%158.00M
-64.03%64.60M
204.07%130.30M
-13.64%123.50M
114.57%212.00M
30.05%179.60M
-209.14%-125.20M
3304.76%143.00M
59.87%98.80M
33.82%138.10M
-146.39%-40.50M
-95.28%4.20M
453.14%61.80M
投资净额
-366.90%-135.40M
-3664.79%-506.20M
22.55%-52.90M
-896.36%-196.70M
-2.84%-29.00M
125.82%14.20M
66.15%-68.30M
125.39%24.70M
77.60%-28.20M
-30.64%-55.00M
-74.57%-201.80M
-58.73%-97.30M
-500.96%-125.90M
-33.23%-42.10M
-587.76%-115.60M
51.43%-61.30M
134.58%31.40M
-150.08%-31.60M
116.05%23.70M
-600.79%-126.20M
融资净额
2021.21%63.40M
26.97%-86.10M
112.86%37.30M
72.73%45.60M
98.87%-3.30M
-268.67%-117.90M
-919.21%-290.00M
40.43%26.40M
-10203.45%-293.00M
752.44%69.90M
43.90%35.40M
64.91%18.80M
101.05%2.90M
34.43%8.20M
1266.67%24.60M
52.00%11.40M
-9313.33%-276.40M
-59.60%6.10M
101.00%1.80M
200.00%7.50M

常见问题

Neurocrine Biosciences Inc的总收入是多少？

根据Neurocrine Biosciences Inc的FY2025财报，总收入达到了2.86B（同比变化2.36B）。

Neurocrine Biosciences Inc的流动资产是多少？

根据Neurocrine Biosciences Inc的FY2025财报，流动资产为2.52B（同比变化46.27）。

Neurocrine Biosciences Inc的总资产是多少？

根据Neurocrine Biosciences Inc的FY2025财报，Neurocrine Biosciences Inc的总资产为4.63B（同比变化24.55）。

Neurocrine Biosciences Inc的总负债是多少？

根据Neurocrine Biosciences Inc的FY2025财报，Neurocrine Biosciences Inc的总负债为1.38B（同比变化22.09）。

Neurocrine Biosciences Inc的总权益是多少？

根据Neurocrine Biosciences Inc的FY2025财报，Neurocrine Biosciences Inc的总权益为3.25B（同比变化25.62）。

Neurocrine Biosciences Inc的净营业收入是多少？

根据Neurocrine Biosciences Inc的FY2025财报，Neurocrine Biosciences Inc的净营业收入为636.50M（同比变化9.18）。

Neurocrine Biosciences Inc的净投资是多少？

根据Neurocrine Biosciences Inc的FY2025财报，Neurocrine Biosciences Inc的净投资为-264.40M（同比变化-108.52）。

Neurocrine Biosciences Inc的净融资是多少？

根据Neurocrine Biosciences Inc的FY2025财报，Neurocrine Biosciences Inc的净融资为-38.30M（同比变化92.13）。

Neurocrine Biosciences Inc的每股收益（EPS）是多少？

根据Neurocrine Biosciences Inc的FY2025财报，每股收益（EPS）为4.81（同比变化41.50）。

Neurocrine Biosciences Inc的净利润是多少？

根据Neurocrine Biosciences Inc的FY2025财报，净利润为478.60M（同比变化40.23）。

Neurocrine Biosciences Inc的净利润率是多少？

根据Neurocrine Biosciences Inc的FY2025财报，净利润率为16.73（同比变化15.46）。

Neurocrine Biosciences Inc的毛利率是多少？

根据Neurocrine Biosciences Inc的FY2025财报，毛利率为98.18（同比变化-0.38）。

Neurocrine Biosciences Inc的股东权益回报率（ROE）是多少？

根据Neurocrine Biosciences Inc的FY2025财报，股东权益回报率（ROE）为16.38（同比变化15.72）。

Neurocrine Biosciences Inc的资产回报率（ROA）是多少？

根据Neurocrine Biosciences Inc的FY2025财报，资产回报率（ROA）为11.46（同比变化17.05）。

Neurocrine Biosciences Inc的营业利润是多少？

根据Neurocrine Biosciences Inc的FY2025财报，营业利润为636.50M（同比变化9.18）。
tradingkey.logo
风险提示：我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐，且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险，包括可能损失投资的本金，且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告，并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
一般使用条款
隐私政策
Cookie政策